Search results for "droni."

showing 10 items of 596 documents

Anti-tumor activity of CpG-ODN aerosol in mouse lung metastases

2013

Studies in preclinical models have demonstrated the superior anti-tumor effect of CpG oligodeoxynucleotides (CpG-ODN) when administered at the tumor site rather than systemically. We evaluated the effect of aerosolized CpG-ODN on lung metastases in mice injected with immunogenic N202.1A mammary carcinoma cells or weakly immunogenic B16 melanoma cells. Upon reaching the bronchoalveolar space, aerosolized CpG-ODN activated a local immune response, as indicated by production of IL-12p40, IFN-γ and IL-1β and by recruitment and maturation of DC cells in bronchoalveolar lavage fluid of mice. Treatment with aerosolized CpG-ODN induced an expansion of CD4+ cells in lung and was more efficacious tha…

CD4-Positive T-LymphocytesLung NeoplasmsInterleukin-1betaMelanoma ExperimentalAntineoplastic AgentsInterferon-gammaMiceCell Line TumorAnimalsHumansNeoplasm MetastasisAerosolsInterleukin-12 Subunit p40cpg-odnlung cancer microenvironment inflammationlung metastasesDendritic CellsGene Expression Regulation NeoplasticMice Inbred C57BLOligodeoxyribonucleotidesFemaleaerosol deliveryClodronic Acidaerosol delivery; cpg-odn; lung metastases; miceImmunosuppressive AgentsNeoplasm Transplantation
researchProduct

Transverse-momentum-dependent Multiplicities of Charged Hadrons in Muon-Deuteron Deep Inelastic Scattering

2017

A semi-inclusive measurement of charged hadron multiplicities in deep inelastic muon scattering off an isoscalar target was performed using data collected by the COMPASS Collaboration at CERN. The following kinematic domain is covered by the data: photon virtuality $Q^{2}>1$ (GeV/$c$)$^2$, invariant mass of the hadronic system $W > 5$ GeV/$c^2$, Bjorken scaling variable in the range $0.003 < x < 0.4$, fraction of the virtual photon energy carried by the hadron in the range $0.2 < z < 0.8$, square of the hadron transverse momentum with respect to the virtual photon direction in the range 0.02 (GeV/$c)^2 < P_{\rm{hT}}^{2} < 3$ (GeV/$c$)$^2$. The multiplicities are pres…

CERN LabComputerSystemsOrganization_COMPUTERSYSTEMIMPLEMENTATIONMULTIPLICITIESdimension: 3PT DEPENDENTComputingMethodologies_IMAGEPROCESSINGANDCOMPUTERVISIONFOS: Physical sciencesComputerApplications_COMPUTERSINOTHERSYSTEMStarget: isoscalarmuon deuteron: deep inelastic scattering[PHYS.NEXP]Physics [physics]/Nuclear Experiment [nucl-ex]nucl-extransverse momentum dependencehadron: transverse momentumSIDISCOMPASSGeneralLiterature_MISCELLANEOUSHigh Energy Physics - Experimentscaling: BjorkenSubatomär fysikcharged particle: multiplicityHigh Energy Physics - Experiment (hep-ex)[ PHYS.HEXP ] Physics [physics]/High Energy Physics - Experiment [hep-ex]mass: hadronicSubatomic Physics[PHYS.HEXP]Physics [physics]/High Energy Physics - Experiment [hep-ex]Nuclear Physics - Experiment[ PHYS.NEXP ] Physics [physics]/Nuclear Experiment [nucl-ex]Nuclear Experiment (nucl-ex)quantum chromodynamics: perturbation theoryNuclear ExperimentNuclear ExperimentDIShep-exhadron: multiplicityeffect: nonperturbativeperturbation theory: higher-orderCERN SPSphoton: energysemi-inclusive reactionComputingMethodologies_PATTERNRECOGNITIONkinematicsDIS; SIDIS; MULTIPLICITIES; PT DEPENDENTHigh Energy Physics::ExperimentParticle Physics - Experimentexperimental resultsphoton: virtual
researchProduct

Search for CP violation using T-odd correlations in D-0 -> K+K-pi(+)pi(-) decays

2014

A search for $CP$ violation using $T$-odd correlations is performed using the four-body $D^0 \to K^+K^-\pi^+\pi^-$ decay, selected from semileptonic $B$ decays. The data sample corresponds to integrated luminosities of $1.0\,\text{fb}^{-1}$ and $2.0\,\text{fb}^{-1}$ recorded at the centre-of-mass energies of 7 TeV and 8 TeV, respectively. The $CP$-violating asymmetry $a_{CP}^{T\text{-odd}}$ is measured to be $(0.18\pm 0.29\text{(stat)}\pm 0.04\text{(syst)})\%$. Searches for $CP$ violation in different regions of phase space of the four-body decay, and as a function of the $D^0$ decay time, are also presented. No significant deviation from the $CP$ conservation hypothesis is found.

CP violation Charm physics Hadron-Hadron Scattering Flavor physics14.40.Lb01 natural sciencesSettore FIS/04 - Fisica Nucleare e SubnucleareHigh Energy Physics - ExperimentFlavor physics[PHYS.HEXP]Physics [physics]/High Energy Physics - Experiment [hep-ex]ASTRONOMY & ASTROPHYSICSQCmedia_commonCharm physicsPhysicsHadronic decays of charmed mesonCharm physics; CP violation; Flavor physics; Hadron-Hadron ScatteringPhysicsPHYSICS PARTICLES & FIELDSParticle physicsCharge conjugation parity time reversal and other discrete symmetrieDecay timeCP violationPhysical Sciences13.25.FtCP violationFísica nuclearLHCParticle Physics - ExperimentTRIPLE-PRODUCT CORRELATIONSPACS: 13.25.Ft 11.30.ErCharm physicNuclear and High Energy PhysicsParticle physicsmedia_common.quotation_subjectLHCb - Abteilung HofmannHadronsAsymmetryNONuclear physicsTheoryofComputation_ANALYSISOFALGORITHMSANDPROBLEMCOMPLEXITY0103 physical sciencesPiSDG 7 - Affordable and Clean Energy010306 general physicsLarge Hadron Collider (France and Switzerland)Science & Technology/dk/atira/pure/sustainabledevelopmentgoals/affordable_and_clean_energyHadron-Hadron Scatteringhep-ex010308 nuclear & particles physicsGran Col·lisionador d'HadronsCharm physics; CP violation; Flavor physics; Hadron-Hadron Scattering; Nuclear and High Energy PhysicsBABAR detectorHEPANGULAR-CORRELATIONSLHCbFlavor physicPhase spaceBaBar11.30.ErFísica de partículesExperimentsCharmed mesons (|C|>0 B=0)
researchProduct

Ibandronate Shows Marked Pain Relief and a Favorable Renal Safety Profile – Updated Results of a Non Interventional Study in Breast Cancer Patients w…

2009

Abstract Background: Bisphosphonates (BP), the current standard of care for patients with metastatic bone disease (MBD) due to breast cancer (BC), effectively reduce the incidence of skeletal related events (SRE) and the severity of bone pain. However, BP treatment may adversely affect kidney function and thus renal safety is a key determinant of BP risk/benefit assessment. In randomized clinical trials (RCT), Ibandronate (IBA), a third generation amino-BP available in IV and oral formulations, has demonstrated sustained effects on SRE and bone pain with a low incidence of renal adverse events. To verify those results under real life conditions, a large-scale non interventional study (NIS) …

Cancer ResearchCreatininemedicine.medical_specialtyBone diseasebusiness.industryAnalgesicUrologyRenal functionmedicine.diseaseInterim analysisSurgerychemistry.chemical_compoundZoledronic acidBreast cancerOncologychemistrymedicinemedicine.symptomBone painbusinessmedicine.drugCancer Research
researchProduct

Performance of jet substructure techniques for large-$R$ jets in proton-proton collisions at $\sqrt{s}$ = 7 TeV using the ATLAS detector

2013

This paper presents the application of a variety of techniques to study jet substructure. The performance of various modified jet algorithms, or jet grooming techniques, for several jet types and event topologies is investigated for jets with transverse momentum larger than 300 GeV. Properties of jets subjected to the mass-drop filtering, trimming, and pruning algorithms are found to have a reduced sensitivity to multiple proton-proton interactions, are more stable at high luminosity and improve the physics potential of searches for heavy boosted objects. Studies of the expected discrimination power of jet mass and jet substructure observables in searches for new physics are also presented.…

Ciencias FísicasPhysics beyond the Standard ModelHadronMonte Carlo method01 natural sciencesHigh Energy Physics - Experiment//purl.org/becyt/ford/1 [https]High Energy Physics - Experiment (hep-ex)Jets[PHYS.HEXP]Physics [physics]/High Energy Physics - Experiment [hep-ex]Invariant massNuclear ExperimentHADRONIC JEThadron-hadron scatteringQCPhysicsLarge Hadron ColliderAtlas (topology)Settore FIS/01 - Fisica SperimentaleObservableATLASPhysical SciencesComputingMethodologies_DOCUMENTANDTEXTPROCESSINGproton–proton collisionLHCCIENCIAS NATURALES Y EXACTASParticle Physics - ExperimentParticle physicsNuclear and High Energy PhysicsCiências Naturais::Ciências Físicas530 PhysicsAstrophysics::High Energy Astrophysical Phenomena:Ciências Físicas [Ciências Naturais]FOS: Physical sciencesddc:500.2530Nuclear physics0103 physical sciencesFysikddc:530High Energy Physics010306 general physicsCiencias ExactasScience & TechnologyHadron-Hadron ScatteringATLAS detector010308 nuclear & particles physicsFísica//purl.org/becyt/ford/1.3 [https]AstronomíaHADRON-HADRON COLLISIONSExperimental High Energy PhysicsSubstructureHigh Energy Physics::Experiment
researchProduct

Efficient killing of human colon cancer stem cells by gammadelta T lymphocytes

2009

Colon cancer comprises a small population of cancer stem cells (CSC) that is responsible for tumor maintenance and resistant to cancer therapies, possibly allowing for tumor recapitulation once treatment stops. We previously demonstrated that such chemoresistance is mediated by autocrine production of IL-4 through the up-regulation of antiapoptotic proteins. Several innate and adaptive immune effector cells allow for the recognition and destruction of cancer precursors before they constitute the tumor mass. However, cellular immune-based therapies have not been experimented yet in the population of CSCs. Here, we show that the bisphosphonate zoledronate sensitizes colon CSCs to Vgamma9Vdelt…

Cytotoxicity ImmunologicDiphosphonatesTerpenesT-LymphocytesImidazolesReceptors Antigen T-Cell gamma-deltaZoledronic AcidColon cancer stem cells gamma delta T cellsNK Cell Lectin-Like Receptor Subfamily KColonic NeoplasmsNeoplastic Stem CellsCytokinesHumansChromaffin GranulesImmunotherapy
researchProduct

Nuclear modification of forward Drell-Yan production at the LHC

2017

Forward Drell-Yan production at high energy can provide important constraints on gluon densities at small $x$, in the saturation regime. In this work we focus on the nuclear modification of this process, which could be measured at the LHC in the near future. For this we employ the color dipole approach, using the optical Glauber model to relate the dipole cross section of a nucleus to the one of a proton. Combining these results with our earlier results for forward $J/\psi$ production, we compute the ratio of the nuclear modification factors of these two processes. This observable was recently suggested as a way to distinguish between initial and final state effects in forward particle prod…

Drell-Yan processParticle physicsProtonNuclear TheoryFOS: Physical scienceshiukkasfysiikka01 natural sciences7. Clean energy114 Physical sciencesNuclear physicsHigh Energy Physics - Phenomenology (hep-ph)0103 physical sciences010306 general physicsNuclear ExperimentQuantum chromodynamicsPhysicsLarge Hadron Colliderta114010308 nuclear & particles physicshigh energy hadronic collisionsDrell–Yan processObservableGluonDipoleHigh Energy Physics - PhenomenologyGlauber
researchProduct

Alendronate-related oral mucosa ulcerations

2000

Alendronate is widely used in the treatment of osteoporosis and other bone diseases. Although it is considered a well-tolerated drug, there are numerous reports of adverse effects on the mucosa in the upper aerodigestive tract, with oesophagitis as the most common complication. The strict regulations for the proper administration of the drug indicate that these side effects might well be the result of a direct, irritant mechanism on the upper aerodigestive tract. We present two clinical cases of patients who developed extensive palatal ulcers as a result of taking alendronate. We discuss possible mechanisms implicated in the production of the ulcers and some clinical factors of interest.

DrugCancer Researchmedicine.medical_specialtyBone diseasebusiness.industryAlendronic acidmedia_common.quotation_subjectOsteoporosismedicine.diseaseDermatologyPathology and Forensic MedicineSurgerymedicine.anatomical_structureOtorhinolaryngologymedicinePeriodonticsOral SurgeryOral mucosaAdverse effectbusinessComplicationAdverse drug reactionmedicine.drugmedia_commonJournal of Oral Pathology & Medicine
researchProduct

Could the Combined Administration of Bone Antiresorptive Drug, Taxanes, and Corticosteroids Worsen Medication Related Osteonecrosis of the Jaws in Ca…

2018

The study presents a report of 58 metastatic cancer patients who developed osteonecrosis of the jaws after being treated with zoledronic acid and taxanes, plus corticosteroids. A retrospective analysis of data registered in the archives of two Italian osteonecrosis of the jaws treatment centers, who are based at the University of Messina and at the University of Palermo, was performed in order to study, in these patients, demographic data and characteristics such as frequency of cancer location, lines of therapy, frequency of cancer drugs, presence/absence of oral trigger, number, location, and stage of jaw osteonecrosis. It was found that the majority of patients developed advanced stages …

DrugGenetics and Molecular Biology (all)Malemedicine.medical_specialtyExacerbationArticle SubjectImmunology and Microbiology (all)media_common.quotation_subjectlcsh:MedicineClinical manifestationBiochemistryGeneral Biochemistry Genetics and Molecular Biology03 medical and health sciences0302 clinical medicineAdrenal Cortex HormonesInternal medicineNeoplasmsmedicineHumansDrug InteractionsStage (cooking)media_commonRetrospective StudiesBiochemistry Genetics and Molecular Biology (all)General Immunology and MicrobiologyBone Density Conservation AgentsDiphosphonatesbusiness.industrylcsh:ROsteonecrosisSoft tissueCancer030206 dentistryGeneral Medicinemedicine.diseaseZoledronic acidBiochemistry Genetics and Molecular Biology (all) Immunology and Microbiology (all)Italy030220 oncology & carcinogenesisBisphosphonate-Associated Osteonecrosis of the JawFemaleTaxoidsbusinessOsteonecrosis of the jawBiochemistry Genetics and Molecular Biology (all); Immunology and Microbiology (all)medicine.drugResearch ArticleBioMed Research International
researchProduct

Preventive effect of risedronate on bone loss and frailty fractures in elderly women treated with anastrozole for early breast cancer.

2011

The aim of this study was to assess the effect of adjuvant anastrozole, alone or associated with risedronate, on BMD and bone fracture risk in women more than 70 years old with hormone receptor-positive early breast cancer (EBC). In a group of 51 elderly women (aged 76.4 ± 5.0 years) considered for adjuvant aromatase inhibitors for EBC, 24 patients with T-scores ≥ -2 and no prevalent fractures received anastrozole 1 mg/day (group A), and 27 patients with T-scores < -2, or with T-scores ≥ -2 and prevalent fractures (group B), received anastrozole (1 mg/day) plus risedronate (35 mg/week). Both groups received supplementation with 1 g calcium carbonate and 800 IU vitamin D per day. Differen…

Endocrinology Diabetes and MetabolismOsteoporosisSeverity of Illness IndexCohort StudiesEndocrinologyBone DensityOrthopedics and Sports MedicineVitamin DAromataseOsteoporosis PostmenopausalAged 80 and overBone Density Conservation AgentsbiologyAromatase InhibitorsEtidronic AcidGeneral MedicineCombined Modality Therapymedicine.anatomical_structureFemaleRisedronic Acidmedicine.drugmusculoskeletal diseasesmedicine.medical_specialtyAntineoplastic Agents HormonalUrologyAnastrozoleBreast NeoplasmsAnastrozoleCalcium CarbonateNitrilesmedicineVitamin D and neurologyHumansBone ResorptionAgedNeoplasm StagingFemoral neckTrochanterbusiness.industryBone fractureTriazolesmedicine.diseaseSurgeryEarly breast cancer Anastrozole Osteoporosis Vertebral fractures ElderlyDietary SupplementsOrthopedic surgerybiology.proteinbusinessOsteoporotic FracturesFollow-Up Studies
researchProduct